These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17579193)
41. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. Traish AM; Gooren LJ J Sex Med; 2010 Nov; 7(11):3758-64. PubMed ID: 20722789 [TBL] [Abstract][Full Text] [Related]
42. Short- and long-term clinical skin effects of testosterone treatment in trans men. Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810 [TBL] [Abstract][Full Text] [Related]
43. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. Anderson RA; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547 [TBL] [Abstract][Full Text] [Related]
44. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study). Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A; Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040 [TBL] [Abstract][Full Text] [Related]
45. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review. Velho I; Fighera TM; Ziegelmann PK; Spritzer PM Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177 [TBL] [Abstract][Full Text] [Related]
46. Effects of testosterone supplementation in the aging male. Tenover JS J Clin Endocrinol Metab; 1992 Oct; 75(4):1092-8. PubMed ID: 1400877 [TBL] [Abstract][Full Text] [Related]
47. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
48. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572 [TBL] [Abstract][Full Text] [Related]
49. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido). Moisey R; Swinburne J; Orme S Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal men. Raynaud JP; Legros JJ; Rollet J; Augès M; Bunouf P; Sournac M; Fiet J J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):168-76. PubMed ID: 18325757 [TBL] [Abstract][Full Text] [Related]
51. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men. Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA J Androl; 2007; 28(5):679-88. PubMed ID: 17460095 [TBL] [Abstract][Full Text] [Related]
52. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity. Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918 [TBL] [Abstract][Full Text] [Related]
53. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency. Park NC; Yan BQ; Chung JM; Lee KM Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792 [TBL] [Abstract][Full Text] [Related]
54. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573 [TBL] [Abstract][Full Text] [Related]
55. Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration. Gava G; Mancini I; Cerpolini S; Baldassarre M; Seracchioli R; Meriggiola MC Clin Endocrinol (Oxf); 2018 Dec; 89(6):878-886. PubMed ID: 30025172 [TBL] [Abstract][Full Text] [Related]
56. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. Giltay EJ; Toorians AW; Sarabdjitsingh AR; de Vries NA; Gooren LJ J Endocrinol; 2004 Jan; 180(1):107-12. PubMed ID: 14709149 [TBL] [Abstract][Full Text] [Related]
57. Physical and hormonal evaluation of transsexual patients during hormonal therapy. Meyer WJ; Finkelstein JW; Stuart CA; Webb A; Smith ER; Payer AF; Walker PA Arch Sex Behav; 1981 Aug; 10(4):347-56. PubMed ID: 6794543 [TBL] [Abstract][Full Text] [Related]
58. The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. Goh HH; Loke DF; Ratnam SS Maturitas; 1995 Jan; 21(1):65-70. PubMed ID: 7731386 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study. Wolf J; Keipert D; Motazedi H; Ernst M; Nettleship J; Gooren L Aging Male; 2017 Dec; 20(4):225-234. PubMed ID: 28812471 [TBL] [Abstract][Full Text] [Related]